Minoxidil

Minoxidil

SCHEMBL29698

Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9KCNJ11

The experimentally established mechanism targets of Minoxidil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
HRH4 Q9H3N8 6/20 0.45
NUDT1 P36639 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.44
CYP1A2 P05177 1/20 0.44
KMT2A Q03164 1/20 0.44
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CHRM3 P20309 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
CASP1 P29466 1/20 0.39
CASP4 P49662 1/20 0.39
CASP5 P51878 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Minoxidil SCHEMBL8860979 1.00 SMN1; SMN2 (0.47) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL638820 1.00 SMN1; SMN2 (0.47) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL29365549 1.00 SMN1; SMN2 (0.47) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL5080820 0.98 SMN1; SMN2 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL7634414 0.98 SMN1; SMN2 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL6242048 0.98 SMN1; SMN2 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL3137104 0.98 SMN1; SMN2 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL8080441 0.98 SMN1; SMN2 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
SCHEMBL5309809 0.98 HRH4 (0.46) SMN1; SMN2CRHBPCRHR2HRH4NUDT1
Minoxidil SCHEMBL22189162 0.92 SMN1; SMN2 (0.42) SMN1; SMN2CRHBPCRHR2HRH4NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 40051 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144791-A1 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL VERADERMICS, INCORPORATED (US) 2026-05-28 US claimed
US-20260144790-A1 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL VERADERMICS, INCORPORATED (US) 2026-05-28 US claimed
CN-122080930-A Minoxidil-based tunable room-temperature phosphorescent carbon dot composite material, preparation method and application thereof in dynamic information encryption 2026-05-26 CN claimed
CN-120771261-B Composition containing cerium oxide nano enzyme and application thereof SHANDONG HUBBLE KISEN BIOLOGICAL TECHNOLOGY Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122070900-A In situ gel composition containing penomelin 南京迈诺威医药科技有限公司 2026-05-22 CN claimed
WO-2026107401-A2 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF POLYLACTIC ACID FOR HAIR GROWTH DURAIRAJ KALPNA KAY (US) 2026-05-21 WO claimed
WO-2026106917-A1 EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL BioPhysics Pharma, Inc. (US) 2026-05-21 WO claimed
CN-122070133-A Pharmaceutical compositions containing androgen receptor inhibitors/antagonists, methods and uses 苏州开拓药业股份有限公司 2026-05-19 CN claimed
CN-117137867-B Foam type cation nanoemulsion hair growth promoting liquid and preparation method thereof 苏州大学 2026-05-19 CN claimed
CN-122060683-A Human mesenchymal stem cell edited by RSPO3 mRNA and application thereof 四川康德赛医疗科技有限公司 2026-05-19 CN claimed
EP-0081094-A1 Substituted omega-amino-carboxymethyldipeptide antihypertensive agents MERCK & CO. INC. (US) 1983-06-15 EP claimed
EP-0079522-A1 N-Carboxymethyl(amidino)lysyl-proline antihypertensive agents MERCK & CO. INC. (US) 1983-05-25 EP claimed
EP-0061186-A1 Dipeptides containing thialysine and homologs as antihypertensives MERCK & CO. INC. (US) 1982-09-29 EP claimed
EP-0061187-A1 Bicyclic lactams as antihypertensives MERCK & CO. INC. (US) 1982-09-29 EP claimed
EP-0049842-A2 Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates MERCK & CO. INC. (US) 1982-04-21 EP claimed
EP-0049505-A2 Substituted caprolactam derivatives, a process for preparing and a pharmaceutical composition containing the same, and intermediates MERCK & CO. INC. (US) 1982-04-14 EP claimed
EP-0046289-A2 Substituted enantholactam derivatives as antihypertensives, a process for preparing and a pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP claimed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP claimed
US-4308271-A PYRIMIDINE OXIDE DERIVATIVES TO INCREASE PRODUCTION THE UPJOHN COMPANY (US) 1981-12-29 US claimed
US-4282228-A Animal feed and process THE UPJOHN COMPANY (US) 1981-08-04 US claimed